Question

What are biphasic liquid dosage forms? Discuss in brief

07 Sep 2024
Answer :
Word Count : 671

Biphasic liquid dosage forms are pharmaceutical preparations that consist of two immiscible liquid phases, typically an oil phase and an aqueous phase. These formulations are often used for delivering active pharmaceutical ingredients (APIs) that exhibit poor solubility in either water or oils, requiring a combination of both phases to improve the bioavailability, stability, and effectiveness of the drug.

Biphasic liquid dosage forms are commonly seen in suspensions, emulsions, and certain types of liquid formulations, where one phase is dispersed in the other. The two phases are not readily soluble in each other, leading to the creation of a heterogeneous system that requires special formulation techniques to ensure stability and uniformity.

### Types of Biphasic Liquid Dosage Forms

1. Emulsions: These are the most common type of biphasic liquid dosage forms, typically involving an oil phase dispersed in an aqueous phase (O/W emulsion) or vice versa (W/O emulsion). Emulsions are stabilized by emulsifying agents or surfactants that lower the interfacial tension between the two phases, preventing them from ________ __________ ________ _____ ____ ______ ______ ______.
_____ ____ _____ _____ _____ ___ _____.
___ __________ _______ ____ ____ ________ _____.
__________ _______ ______ ________ ____.
___ ____ ____ _________ ______.
______ __________ ____ ______ ____.
___ __________ __________ ______ __________ ______ _______ ______ ________.
_________ ________ ______ ________ ___ _____ _____ _______ ________ ___ ____.
_________ ___ ______ __________ ______ _____ __________ ____ ____ ____ ___ ________.
___ _______ _________ ___ ______ ______ ____ _________ ________ _______.
________ _________ _____ _____ ___ _____ ______ _________ ___ ______ ____ ___.
_________ _____ _________ ____ _________ __________ _________ ________ _______ ___.
_____ __________ ______ _____ _______.
________ _________ _________ ________ ____ ________ ___ _____ ______ _________ __________ ______.
_____ _______ ______ _________ _____ _________.
____ _____ _______ _____ ___.
________ ____ ____ ____ ___ __________ _____.
___ _________ _________ ___ ______ ______ ______.
_____ ____ __________ ________ _______ ________ _______ _______ _______ ________ ________.
____ __________ _________ ____ _____ ________ _____ ___ ______ _________ _______.
_____ _______ _________ ____ ___ _______ _______ ______ ____.
_________ __________ ___ _________ _____ _______ _________.
_____ _______ _____ _______ ____.
____ _______ _______ ___ _______ ___ __________ _________ ________ _________ ____ __________.
______ ______ ____ ______ _______ _______ _______.
_____ ___ ___ _______ _______ ___ __________ ______.
________ __________ ______ _____ ______.
___ ____ ____ __________ _____ ____ _____ _____.
_______ __________ ___ __________ ___ ___.
_______ _________ ________ _____ _____ ____ ______ _______ _____.
____ __________ _____ _____ __________ ______ __________ ___ _________ _________ _____ ____.
_______ _________ ______ __________ ___ _____ _________.
_______ _____ __________ _____ ________ ____ _____.
______ _______ _______ __________ ___ _______ _____.
_________ ________ _______ ____ ______ _______ ____ ___ ________ __________ _________.
________ _____ _____ ________ ________ ____ ________.
___ __________ _____ ____ _____ _________ _________ __________ ___ _____ __________.
_____ ________ ______ __________ ____ ____ ___.
______ ______ ____ ____ ______ _______ ____ _____ _______.
_________ _________ _________ ________ _______ __________ ______.
___ _________ _______ _______ _______ ___ ____ ________ ___ ________ ________ _____.
_____ ____ _____ _______ _____ ______ __________ _________.
________ _____ _________ ____ ____ ________ _______ ___ __________ _______.
_____ ________ ______ ______ ___ ______ ____.
_____ _____ __________ ____ _______ _____ _____ _______ ________ _________ _____ _____.
_______ _________ _____ __________ ________ ___ ______ _____.
_____ ___ ______ _______ ________ _______ ______.
_____ _______ ____ _________ ____ _______ _______ ________ ___.
_______ ____ ____ _______ ____.
___ __________ ____ _________ ____ ____.
______ ___ _________ _______ ____ _____ ________ _______ ___ __________ _________ ______.
____ _______ __________ __________ ____.
______ ________ __________ ___ ______ __________ ___ __________.
_________ _____ _______ _____ _______ _____ _________ ____ ______ ____.
_______ ____ _______ ___ _______ _________ ________ ____ _______.
_________ _____ ______ _____ ____ _______ __________.
_________ __________ ____ ___ ________ _______.
_________ __________ ________ _____ _________ _______ __________.
_________ ________ ______ __________ ______.
_______ _________ __________ ____ ____.
__________ _________ _______ ________ ______ ___ ______ ______ ___ ___ ________.
________ ____ __________ ________ ________ _________ _____ _______ ______.
Get Full Answer on WhatsApp

IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★
Top
📞
Call Support Instant phone assistance What are biphasic liquid dosage forms? Discuss in brief
🟢
WhatsApp Chat Fast live messaging
Email Us Business enquiries & support